Cost-of-illness of melanoma in Europe - a modelling approach

Journal of the European Academy of Dermatology and Venereology : JEADV
M KrenselM Augustin

Abstract

Malignant melanoma is accounting for the vast majority of skin cancer death. The treatment and productivity loss due to morbidity or premature mortality are associated with costs for society. There are few cost-of-illness (COI) studies on malignant melanoma in European countries from societal perspective and currently there is no publication analysing the COI in all European countries. The objective of the present study was to comparatively estimate COI of malignant melanoma in the European countries based on an identical approach. Cost information was obtained from results of a systematic literature research. For countries with no available cost information, a model for imputation of cost data was developed. Country-specific costs were modelled on the national gross domestic product, health expenditures, gross national income and epidemiological data. The adjustment for purchasing power parity allowed a comparison across countries. Crude national costs of malignant melanoma ranged between € 1.1 million in Iceland and € 543.8 million in Germany and resulted in € 2.7 billion for all EU/EFTA states. Estimated crude costs per patient were lowest in Bulgaria (€ 6422) and highest in Luxembourg (€ 50 734). The share of direct costs v...Continue Reading

References

Jan 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P Boyle
Mar 17, 2001·PharmacoEconomics·E J BeckK Tolley
May 25, 2002·Health Affairs·Uwe E ReinhardtGerard F Anderson
Apr 21, 2004·International Journal of Technology Assessment in Health Care·Gunnar H NilssonHenrik Ullén
Jun 16, 2004·CA: a Cancer Journal for Clinicians·Charles M BalchJohn F Thompson
Aug 13, 2004·Health Promotion International·Warren R StantonPeter Anderson
May 10, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Patrik Andlin-SobockiJes Olesen
Jan 13, 2006·Dementia and Geriatric Cognitive Disorders·A WimoB Winblad
Sep 13, 2007·Health Affairs·Gerard F AndersonUwe E Reinhardt
Jan 30, 2008·Melanoma Research·Julie ChevalierMarie-Françoise Avril
May 15, 2008·Journal of Medical Imaging and Radiation Oncology·M J Veness
Sep 10, 2008·Acta Dermato-venereologica·Gustav TinghögInger Rosdahl
Sep 16, 2008·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·S MorrisN Bosanquet
Jun 13, 2009·Journal of Behavioral Medicine·Nadine A KasparianBettina Meiser
Apr 1, 2007·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Anders WimoLinus Jönsson
Sep 15, 2009·Preventive Medicine·Sophy Ting-Fang ShihTheo Vos
Mar 20, 2010·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Anders WimoLinus Jönsson
May 25, 2011·PharmacoEconomics·Allison Larg, John R Moss
Sep 20, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Anders GustavssonUNKNOWN CDBE2010Study Group
Dec 20, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J OlesenUNKNOWN European Brain Council
Apr 7, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K JohnstonM van Baardewijk
Nov 3, 2012·Journal of Experimental & Clinical Cancer Research : CR·Michele MaioCarlo Lucioni
Jan 12, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Anders WimoUNKNOWN Alzheimer Disease International
Apr 2, 2013·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Joan BentzenHans H Storm
Apr 5, 2013·Journal of Public Health·L Vallejo-TorresJ Verne
Aug 22, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·M ArnoldE de Vries
Aug 5, 2014·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Louisa G Gordon, David Rowell
Aug 12, 2014·Acta Dermato-venereologica·Thérèse Eriksson, Gustav Tinghög
Mar 20, 2015·PharmacoEconomics·Till SeuringMarc Suhrcke
Mar 27, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·J LythC Lindholm
Jul 21, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Ewa StawowczykPaweł Moćko
Sep 1, 2015·Journal of Dental Research·S ListlW Marcenes

❮ Previous
Next ❯

Citations

Feb 8, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·T VestergaardA Bygum
Jun 4, 2019·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Tianhao WuMinxue Shen
Feb 12, 2021·International Journal of Dermatology·Fernando García-SoutoJose-Juan Pereyra-Rodríguez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the European Academy of Dermatology and Venereology : JEADV
M KrenselM Augustin
Bulletin De La Société Des Sciences Médicales Du Grand-Duché De Luxembourg
A BisdorffCost of Disorders of the Brain in Europe Study Group
© 2022 Meta ULC. All rights reserved